WEKO3
アイテム
{"_buckets": {"deposit": "44a705cd-55f0-4467-90be-3d672d92d3c2"}, "_deposit": {"created_by": 1, "id": "44941", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "44941"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00044941", "sets": ["1"]}, "author_link": ["446302", "446304", "446303", "446309", "446305", "446307", "446308", "446306"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2007-05", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "577", "bibliographicPageStart": "571", "bibliographicVolumeNumber": "34", "bibliographic_titles": [{"bibliographic_title": "Nuclear Medicine and Biology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The [18F]fluoromethyl analog of the sigma1 selective ligand 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (SA4503) ([18F]FM-SA4503) was prepared and its potential evaluated for the in vivo measurement of sigma1 receptors with positron emission tomography (PET). FM-SA4503 had selective affinity for the sigma1 receptor (Ki for sigma1 receptor, 6.4 nM; Ki for sigma2 receptor, 250 nM) that was compatible with the affinity of SA4503 (Ki for sigma1 receptor, 4.4 nM; Ki for sigma2 receptor, 242 nM). [18F]FM-SA4503 was synthesized by 18F-fluoromethylation of O-demethyl SA4503 in the radiochemical yield of 2.9-16.6% at the end of bombardment with a specific activity of 37.8-283 TBq/mmol at the end of synthesis. In mice, the uptake of [18F]FM-SA4503 in the brain was gradually increased for 30 min after injection, and then decreased. In the blocking study, brain uptake was significantly decreased by co-injection of haloperidol to 32% of control, and FM-SA4503 to 52% of control. In PET study of the monkey brain, high uptake was found in the cerebral cortex, thalamus and striatum. The radioactivity level of [18F]FM-SA4503 in the brain regions gradually increased over a period of 120 min after injection, followed by a stable plateau phase until 180 min after injection. In pretreatment with haloperidol measurement of the monkey brain, the radioactivity level was 22-32% and 11-25% of the baseline at 60 and 180 min, respectively, after injection, suggesting high receptor-specific binding. [18F]FM-SA4503 showed specific binding to sigma1 receptors in mice and monkeys; therefore, [18F]FM-SA4503 has the potential for mapping sigma1 receptors in the brain.", "subitem_description_type": "Abstract"}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1016/j.nucmedbio.2007.03.009", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0969-8051", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kawamura, Kazunori"}], "nameIdentifiers": [{"nameIdentifier": "446302", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsukada, Hideo"}], "nameIdentifiers": [{"nameIdentifier": "446303", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shiba, Kazuhiro"}], "nameIdentifiers": [{"nameIdentifier": "446304", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kimura, Yuichi"}], "nameIdentifiers": [{"nameIdentifier": "446305", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishiwata, Kiichi"}], "nameIdentifiers": [{"nameIdentifier": "446306", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "446307", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "木村 裕一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "446308", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "石渡 喜一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "446309", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/44941", "pubdate": {"attribute_name": "公開日", "attribute_value": "2007-08-15"}, "publish_date": "2007-08-15", "publish_status": "0", "recid": "44941", "relation": {}, "relation_version_is_last": true, "title": ["Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography"], "weko_shared_id": -1}
Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography
https://repo.qst.go.jp/records/44941
https://repo.qst.go.jp/records/449417c4b77ad-81fe-4069-83d6-088d496ddacd
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2007-08-15 | |||||
タイトル | ||||||
タイトル | Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kawamura, Kazunori
× Kawamura, Kazunori× Tsukada, Hideo× Shiba, Kazuhiro× Kimura, Yuichi× Ishiwata, Kiichi× et.al× 木村 裕一× 石渡 喜一 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The [18F]fluoromethyl analog of the sigma1 selective ligand 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (SA4503) ([18F]FM-SA4503) was prepared and its potential evaluated for the in vivo measurement of sigma1 receptors with positron emission tomography (PET). FM-SA4503 had selective affinity for the sigma1 receptor (Ki for sigma1 receptor, 6.4 nM; Ki for sigma2 receptor, 250 nM) that was compatible with the affinity of SA4503 (Ki for sigma1 receptor, 4.4 nM; Ki for sigma2 receptor, 242 nM). [18F]FM-SA4503 was synthesized by 18F-fluoromethylation of O-demethyl SA4503 in the radiochemical yield of 2.9-16.6% at the end of bombardment with a specific activity of 37.8-283 TBq/mmol at the end of synthesis. In mice, the uptake of [18F]FM-SA4503 in the brain was gradually increased for 30 min after injection, and then decreased. In the blocking study, brain uptake was significantly decreased by co-injection of haloperidol to 32% of control, and FM-SA4503 to 52% of control. In PET study of the monkey brain, high uptake was found in the cerebral cortex, thalamus and striatum. The radioactivity level of [18F]FM-SA4503 in the brain regions gradually increased over a period of 120 min after injection, followed by a stable plateau phase until 180 min after injection. In pretreatment with haloperidol measurement of the monkey brain, the radioactivity level was 22-32% and 11-25% of the baseline at 60 and 180 min, respectively, after injection, suggesting high receptor-specific binding. [18F]FM-SA4503 showed specific binding to sigma1 receptors in mice and monkeys; therefore, [18F]FM-SA4503 has the potential for mapping sigma1 receptors in the brain. | |||||
書誌情報 |
Nuclear Medicine and Biology 巻 34, 号 5, p. 571-577, 発行日 2007-05 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0969-8051 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.nucmedbio.2007.03.009 |